Intertrigo Clinical Trial
Official title:
Open-Label Pilot Study of the Efficacy and Safety of Vusion Ointment for the Treatment of Intertrigo
The purpose of this study is to determine if people with moist, red, patches on their skin in body folds would benefit treatment of those areas with an FDA-approved drug called Vusion.
Intertrigo is an inflammatory condition of skin folds, induced or aggravated by heat,
moisture, maceration, friction, or lack of air circulation. It is typically chronic with
insidious onset of itching, burning, and stinging within the affected skin folds. Intertrigo
frequently worsened or colonized by infection, which most commonly is candidal but also may
be bacterial, fungal, or viral. The etiology of diaper dermatitis shows significant overlap
with that of intertrigo. Vusion ointment, a highly effective treatment for diaper dermatitis,
has been used by physicians for the treatment of intertrigo; however, there is a paucity of
data in the literature regarding the use of Vusion ointment in this indication.
This study is the first to formally investigate the efficacy and safety of Vusion ointment
for the treatment of intertrigo.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04325490 -
Tapioca Starch Stimutex AS, Aloe Barbadensis, Rose Hip Oil, Allantoin Comparing With Topical 1% Hydrocortisone Cream
|
Phase 4 | |
| Completed |
NCT03824886 -
Enhancing SKIN Health and Safety in Aged CARE
|
N/A | |
| Not yet recruiting |
NCT05760469 -
Seeing Red: Clinical Assessment Tools for Clinical Trial Decision Support
|
N/A | |
| Not yet recruiting |
NCT06221046 -
Clinical Trial Cream D
|
N/A |